Sex Hustling, Injection Drug Use, and Non-Gay Identification by Men Who Have Sex With Men

1998 ◽  
Vol 25 (7) ◽  
pp. 353-360 ◽  
Author(s):  
CORNELIS A. RIETMEIJER ◽  
RICHARD J. WOLITSKI ◽  
MARTIN FISHBEIN ◽  
NANCY H. CORBY ◽  
DAVID L. COHN
2020 ◽  
Vol 207 ◽  
pp. 107808 ◽  
Author(s):  
Jessica L. Maksut ◽  
Rachel E. Gicquelais ◽  
Kevon-Mark Jackman ◽  
Lisa A. Eaton ◽  
M. Revel Friedman ◽  
...  

2011 ◽  
Vol 15 (7) ◽  
pp. 1561-1569 ◽  
Author(s):  
Angie Ghanem ◽  
Susan J. Little ◽  
Lydia Drumright ◽  
Lin Liu ◽  
Sheldon Morris ◽  
...  

2010 ◽  
Author(s):  
Angie Ghanem ◽  
Susan Little ◽  
Lin Liu ◽  
Sheldon Morris ◽  
Richard Garfein

2020 ◽  
Vol 31 (13) ◽  
pp. 1247-1254
Author(s):  
Nguyen Anh Tuan ◽  
Lisa G Johnston ◽  
Duong Cong Thanh ◽  
Linh-Vi N Le ◽  
Tran Vu Hoang ◽  
...  

Vietnam has been conducting HIV/sexually transmitted infection (STI) integrated bio-behavioral surveillance surveys on men who have sex with men (MSM) as well as other key populations since 2005. Although HIV prevalence in the Vietnamese general population remains below 1%, it is expected to be much higher among MSM. Data on HIV prevalence and sexual and drug use behaviors were collected from MSM in Ho Chi Minh City (HCMC) in 2006 (n = 397), 2009 (n = 399) and 2013 (n = 350) using respondent-driven sampling. Eligible participants were males, aged ≥15 years who reported having manual, oral, or anal sexual activity with males in the past year and lived, worked or socialized in HCMC. HIV seroprevalence among MSM was 5.8% in 2006, 16.1% in 2009 and 12.1% in 2013 and prevalence of at least one STI (syphilis, gonorrhea and/or chlamydia infection) was 11.4% in 2006 and 15.6% in 2009 (no data for 2013). Significant, but small, increasing trends were found for MSM who reported ever testing and receiving results for HIV and for HIV prevalence. No significant changes for condom use, injecting and non-injecting drug use, or and receipt of free condoms were observed. Although a small percentage of MSM reported injecting drugs, HIV was positively associated with ever injecting drugs. Programs targeting MSM should include screening and treatment for injection drug use to most effectively control the HIV/AIDS epidemic among MSM in HCMC.


2015 ◽  
Vol 26 (1) ◽  
pp. 17-22 ◽  
Author(s):  
Ann N Burchell ◽  
Sandra L Gardner ◽  
Tony Mazzulli ◽  
Michael Manno ◽  
Janet Raboud ◽  
...  

BACKGROUND: Internationally, there is a growing recognition that hepatitis C virus (HCV) may be sexually transmitted among HIV-positive men who have sex with men (MSM).OBJECTIVE: To report the first Canadian estimate of HCV seroincidence in 2000 to 2010 and its risk factors among HIV-positive MSM with no known history of injection drug use.METHODS: Data from the Ontario HIV Treatment Network Cohort Study, an ongoing cohort of individuals in HIV care in Ontario, were analyzed. Data were obtained from medical charts, interviews and record linkage with the provincial public health laboratories. The analysis was restricted to 1534 MSM who did not report injection drug use and had undergone ≥2 HCV antibody tests, of which the first was negative (median 6.1 person-years [PY] of follow-up; sum 9987 PY).RESULTS: In 2000 to 2010, 51 HCV seroconversions were observed, an overall incidence of 5.1 per 1000 PY (95% CI 3.9 to 6.7). Annual incidence varied from 1.6 to 8.9 per 1000 PY, with no statistical evidence of a temporal trend. Risk for seroconversion was elevated among men who had ever had syphilis (adjusted HR 2.5 [95% CI 1.1 to 5.5) and men who had acute syphilis infection in the previous 18 months (adjusted HR 2.8 [95% CI 1.0 to 7.9]). Risk was lower for men who had initiated antiretroviral treatment (adjusted HR 0.49 [95% CI 0.25 to 0.95]). There were no statistically significant effects of age, ethnicity, region, CD4 cell count or HIV viral load.CONCLUSIONS: These findings suggest that periodic HCV rescreening may be appropriate in Ontario among HIV-positive MSM. Future research should seek evidence whether syphilis is simply a marker for high-risk sexual behaviour or networks, or whether it potentiates sexual HCV transmission among individuals with HIV.


2015 ◽  
Vol 146 ◽  
pp. e133 ◽  
Author(s):  
H. Hagan ◽  
Joshua Neurer ◽  
Ashly E. Jordan ◽  
Don C. Des Jarlais ◽  
Jennifer Wu ◽  
...  

2021 ◽  
Author(s):  
Jing Zhao ◽  
Charles Green ◽  
Christine Markham ◽  
Kayo Fujimoto ◽  
Alan G. Nyitray ◽  
...  

Abstract Background: This study investigated the association between drug use and Hepatitis C Virus (HCV) infection in HIV-negative men who have sex with men (MSM) who reported drug use but not injection drug use. Methods: This cross-sectional study analyzed the data of 118 HIV-negative MSM who reported drug use but not injection drug use recruited from two inner-city communities between 2004 and 2007. Latent class analysis (LCA) was used to identify drug use latent classes. Multinomial logistic regression analysis was used to evaluate the association between drug use latent class and HCV infection. Results: Four distinct latent classes of drug use were identified: (1) persons >=42 years old who used only crack cocaine, (2) persons about 42 years old who used >2 drugs, (3) persons <42 years old who used >5 drugs, and (4) persons >=42 years old who used >6 drugs. Class 4, persons >= 42 years old who used >6 drugs were significantly associated with HCV infection. Compared with persons about 42 years old who used >2 drugs, persons >=42 years old who used >6 drugs had more than 16 times the odds of having HCV infection (adjusted OR = 16.9, 95%CI: 1.4-205.4), and compared with persons <42 years old who used >5 drugs, persons >=42 years old who used >6 drugs were about 22 times as likely to have HCV infection (adjusted OR=21.8, 95%CI: 1.5-322.8). Conclusions: The subgroup of MSM >=42 years old with non-injection but multiple use of heroin, speedball, and methamphetamine, in addition to crack cocaine and marijuana, had high probability of HCV infection. Public health and education programs, as well as drug treatment and rehabilitation programs, should be developed for this high-risk subgroup to prevent HCV acquisition and transmission.


2006 ◽  
Vol 36 ◽  
pp. S201-S202
Author(s):  
J. Buffington ◽  
P. Murray ◽  
K. Schlanger ◽  
L. Shih ◽  
T. Badsgard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document